Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 436, pseudogene (RNU6-436P) is a non-functional genomic sequence that resembles the functional U6 small nuclear RNA gene but does not produce a mature, active RNA product[5]. U6 snRNA (the functional parent) is a crucial component of the spliceosome, the complex responsible for removing introns from pre-mRNA during RNA splicing in eukaryotic cells[1][3]. U6 snRNA is highly conserved and essential for cell viability due to its role in forming the spliceosomal catalytic core[3]. However, the RNU6-436P pseudogene itself is a genomic relic that likely arose through duplication or retrotransposition events and does not encode a functional transcript or protein[5]. Pseudogenes like RNU6-436P can sometimes have regulatory roles, but there is no evidence for such a role in this case[5]. This gene is not considered a drug target, biomarker, or receptor; its inclusion as a target is incorrect.
None as a pseudogene
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 436, pseudogene (RNU6-436P).